Bcl-2-associated Transcription Factor 1 Ser290 Phosphorylation Mediates DNA Damage Response and Regulates Radiosensitivity in Gastric Cancer

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2021 Aug 10

PMID 34372878

Citations 8

Authors

Jia Liu

Jingyi Li

Zhao Sun

Yangmiao Duan

Fengqin Wang

Guangwei Wei

Jing-Hua Yang

Affiliations

Soon will be listed here.

Abstract

Background: DNA damage response plays critical roles in tumor pathogenesis and radiotherapy resistance. Protein phosphorylation is a critical mechanism in regulation of DNA damage response; however, the key mediators for radiosensitivity in gastric cancer still needs further exploration.

Methods: A quick label-free phosphoproteomics using high-resolution mass spectrometry and an open search approach was applied to paired tumor and adjacent tissues from five patients with gastric cancer. The dysregulated phosphoproteins were identified and their associated-pathways analyzed using Gene Set Enrichment Analysis (GSEA). The mostly regulated phosphoproteins and their potential functions were validated by the specific antibodies against the phosphorylation sites. Specific protein phosphorylation was further analyzed by functional and clinical approaches.

Results: 832 gastric cancer-associated unique phosphorylated sites were identified, among which 25 were up- and 52 down-regulated. Markedly, the dysregulated phosphoproteins were primarily enriched in DNA-damage-response-associated pathways. Particularly, the phosphorylation of Bcl-2-associated transcription factor 1 (BCLAF1) at Ser290 was significantly upregulated in tumor. The upregulation of BCLAF1 Ser290 phosphorylation (pBCLAF1 (Ser290)) in tumor was confirmed by tissue microarray studies and further indicated in association with poor prognosis of gastric cancer patients. Eliminating the phosphorylation of BCLAF1 at Ser290 suppressed gastric cancer (GC) cell proliferation. Upregulation of pBCLAF1 (Ser290) was found in association with irradiation-induced γ-H2AX expression in the nucleus, leading to an increased DNA damage repair response, and a marked inhibition of irradiation-induced cancer cell apoptosis.

Conclusions: The phosphorylation of BCLAF1 at Ser290 is involved in the regulation of DNA damage response, indicating an important target for the resistance of radiotherapy.

Citing Articles

p85β acts as a transcription cofactor and cooperates with BCLAF1 in the nucleus.

Wang P, Mak V, Rao L, Wu Q, Zhou Y, Sharma R Nat Commun. 2025; 16(1):2042.

PMID: 40016211 PMC: 11868507. DOI: 10.1038/s41467-025-56532-3.

Pan-Cancer Analysis Identifies BCLAF1 as a Potential Biomarker for Renal Cell Carcinoma.

Yan H, Wu X, Li H, Yu Z, Jin X Biochem Genet. 2024; .

PMID: 38573525 DOI: 10.1007/s10528-024-10773-x.

iHerd: an integrative hierarchical graph representation learning framework to quantify network changes and prioritize risk genes in disease.

Duan Z, Dai Y, Hwang A, Lee C, Xie K, Xiao C PLoS Comput Biol. 2023; 19(9):e1011444.

PMID: 37695793 PMC: 10513318. DOI: 10.1371/journal.pcbi.1011444.

Unveiling DNA damage repair-based molecular subtypes, tumor microenvironment and pharmacogenomic landscape in gastric cancer.

Kong W, Wang Z, Wang B Front Genet. 2023; 14:1118889.

PMID: 37124627 PMC: 10140566. DOI: 10.3389/fgene.2023.1118889.

UBA1 inhibition contributes radiosensitization of glioblastoma cells blocking DNA damage repair.

Wu C, Shen Y, Shi L, Zhang J, Guo T, Zhou L Front Pharmacol. 2023; 14:1073929.

PMID: 36959858 PMC: 10027716. DOI: 10.3389/fphar.2023.1073929.

References

Hu K, Wang S, Wang Z, Li L, Huang Z, Yu W . Clinicopathological risk factors for gastric cancer: a retrospective cohort study in China. BMJ Open. 2019; 9(9):e030639. PMC: 6756371. DOI: 10.1136/bmjopen-2019-030639. View

Soodgupta D, White L, Yang W, Johnston R, Andrews J, Kohyama M . RAG-Mediated DNA Breaks Attenuate PU.1 Activity in Early B Cells through Activation of a SPIC-BCLAF1 Complex. Cell Rep. 2019; 29(4):829-843.e5. PMC: 6870970. DOI: 10.1016/j.celrep.2019.09.026. View

Lee J, Chung S, Choi J, Han Y, Kim J . Clinicopathologic Characteristics and Long-Term Outcome of Gastric Cancer Patients with Family History: Seven-Year Follow-Up Study for Korean Health Check-Up Subjects. Gastroenterol Res Pract. 2020; 2020:4028136. PMC: 7599414. DOI: 10.1155/2020/4028136. View

Min B, Kim K, Park C, Lee J, Rhee P, Rhee J . Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity. Gastric Cancer. 2014; 18(3):618-26. DOI: 10.1007/s10120-014-0378-7. View

Vohhodina J, Barros E, Savage A, Liberante F, Manti L, Bankhead P . The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export. Nucleic Acids Res. 2017; 45(22):12816-12833. PMC: 5728405. DOI: 10.1093/nar/gkx1046. View

Shao A, Sun H, Geng Y, Peng Q, Wang P, Chen J . Bclaf1 is an important NF-κB signaling transducer and C/EBPβ regulator in DNA damage-induced senescence. Cell Death Differ. 2016; 23(5):865-75. PMC: 4832105. DOI: 10.1038/cdd.2015.150. View

Liu H, Lu Z, Miki Y, Yoshida K . Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage. Mol Cell Biol. 2007; 27(24):8480-91. PMC: 2169390. DOI: 10.1128/MCB.01126-07. View

Li X, He Z, Cheng B, Fang Q, Ma D, Lu T . Effect of BCLAF1 on HDAC inhibitor LMK-235-mediated apoptosis of diffuse large B cell lymphoma cells and its mechanism. Cancer Biol Ther. 2018; 19(9):825-834. PMC: 6154843. DOI: 10.1080/15384047.2018.1472188. View

Kuznetsova K, Solovyeva E, Kuzikov A, Gorshkov M, Moshkovskii S . [Modification of cysteine residues for mass spectrometry-based proteomic analysis: facts and artifacts]. Biomed Khim. 2020; 66(1):18-29. DOI: 10.18097/PBMC20206601018. View

10.

Tong M, Yu C, Shi J, Huang W, Ge S, Liu M . Phosphoproteomics Enables Molecular Subtyping and Nomination of Kinase Candidates for Individual Patients of Diffuse-Type Gastric Cancer. iScience. 2019; 22:44-57. PMC: 6931223. DOI: 10.1016/j.isci.2019.11.003. View

11.

Ashraf N, Hoffe S, Kim R . Adjuvant treatment for gastric cancer: chemotherapy versus radiation. Oncologist. 2013; 18(9):1013-21. PMC: 3780633. DOI: 10.1634/theoncologist.2012-0462. View

12.

Mou S, Yang P, Liu Y, Xu N, Jiang W, Yue W . BCLAF1 promotes cell proliferation, invasion and drug-resistance though targeting lncRNA NEAT1 in hepatocellular carcinoma. Life Sci. 2019; 242:117177. DOI: 10.1016/j.lfs.2019.117177. View

13.

Pilie P, Tang C, Mills G, Yap T . State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol. 2018; 16(2):81-104. PMC: 8327299. DOI: 10.1038/s41571-018-0114-z. View

14.

Liu J, Jiang G, Mao P, Zhang J, Zhang L, Liu L . Down-regulation of GADD45A enhances chemosensitivity in melanoma. Sci Rep. 2018; 8(1):4111. PMC: 5841426. DOI: 10.1038/s41598-018-22484-6. View

15.

Na S, Kim J, Paek E . MODplus: Robust and Unrestrictive Identification of Post-Translational Modifications Using Mass Spectrometry. Anal Chem. 2019; 91(17):11324-11333. DOI: 10.1021/acs.analchem.9b02445. View

16.

Jiang T, Liu B, Wu D, Zhang F . BCLAF1 induces cisplatin resistance in lung cancer cells. Oncol Lett. 2020; 20(5):227. PMC: 7500056. DOI: 10.3892/ol.2020.12090. View

17.

Heroes E, Van der Hoeven G, Choy M, Del Pino Garcia J, Ferreira M, Nys M . Structure-Guided Exploration of SDS22 Interactions with Protein Phosphatase PP1 and the Splicing Factor BCLAF1. Structure. 2019; 27(3):507-518.e5. PMC: 6538287. DOI: 10.1016/j.str.2018.12.002. View

18.

Djuzenova C, Elsner I, Katzer A, Worschech E, Distel L, Flentje M . Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci. Radiat Oncol. 2013; 8:98. PMC: 3653697. DOI: 10.1186/1748-717X-8-98. View

19.

Chouchani E, James A, Fearnley I, Lilley K, Murphy M . Proteomic approaches to the characterization of protein thiol modification. Curr Opin Chem Biol. 2010; 15(1):120-8. PMC: 3087609. DOI: 10.1016/j.cbpa.2010.11.003. View

20.

Zhou X, Li X, Cheng Y, Wu W, Xie Z, Xi Q . BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells. Nat Commun. 2014; 5:4581. DOI: 10.1038/ncomms5581. View